nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Changing patterns of initial drug therapy for the treatment of hypertension in a medicaid population, 1997–2000
|
Weiss, Robert |
|
2002 |
24 |
9 |
p. 1451-1462 12 p. |
artikel |
2 |
Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies
|
Milsom, Ian |
|
2002 |
24 |
9 |
p. 1384-1400 17 p. |
artikel |
3 |
Correction
|
|
|
2002 |
24 |
9 |
p. 1481- 1 p. |
artikel |
4 |
Current therapeutic research
|
|
|
2002 |
24 |
9 |
p. I- 1 p. |
artikel |
5 |
Dear Dr. Walson
|
Novack, Gary D. |
|
2002 |
24 |
9 |
p. 1477-1478 2 p. |
artikel |
6 |
Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study
|
Garber, Alan J. |
|
2002 |
24 |
9 |
p. 1401-1413 13 p. |
artikel |
7 |
HIV in correctional facilities: a challenge and an opportunity
|
Coons, Stephen Joel |
|
2002 |
24 |
9 |
p. 1464-1465 2 p. |
artikel |
8 |
How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience
|
Dewa, Carolyn S. |
|
2002 |
24 |
9 |
p. 1466-1476 11 p. |
artikel |
9 |
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study
|
Dailey III, George E. |
|
2002 |
24 |
9 |
p. 1426-1438 13 p. |
artikel |
10 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis
|
Weiss, Lee R. |
|
2002 |
24 |
9 |
p. 1414-1425 12 p. |
artikel |
11 |
Pegylated interferons for the treatment of chronic hepatitis C infection
|
Luxon, Bruce A. |
|
2002 |
24 |
9 |
p. 1363-1383 21 p. |
artikel |
12 |
Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers
|
Raizman, Michael B. |
|
2002 |
24 |
9 |
p. 1439-1450 12 p. |
artikel |
13 |
The author replies
|
Berdy, Gregg J. |
|
2002 |
24 |
9 |
p. 1478-1480 3 p. |
artikel |